Prof. Dr. Simten DAĞDAŞ

1. Clinical Spectrum and Differential Diagnosis of Adult Thrombotic Microangiopathies: Real-World Experience from a Tertiary Referral Center

Kırkayak N. P., Ozet G., DAĞDAŞ S., CERAN F., ATEŞ İ.

Hematology Reports , cilt.18, sa.4, 2026 (ESCI, Scopus)

2. Bidirectional Temporal Association Between Cytomegalovirus Reactivation and Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Real-World Cohort Study

İşleyen E., DAĞDAŞ S., Kayaaslan B., CERAN F., Pepeler M. S., Kaya A., et al.

Viruses , cilt.18, sa.8, 2026 (SCI-Expanded, Scopus)

3. Comparison of Peripheral Stem Cell Mobilization Results on the Fourth and Fifth Day of G-CSF Treatment in Unrelated Donors

Korkmaz G., Ozet G., CERAN F., Aydın M. S., Pamukcuoglu M., Isleyen E., et al.

Journal of Clinical Apheresis , cilt.41, sa.1, 2026 (SCI-Expanded, Scopus)

4. Prognostic Differences Between P190 and P210 BCR::ABL1 in Patients with Philadelphia-Positive B-cell Acute Lymphoblastic Leukemia

Pepeler M., Oztürk F., Okumus N., Dal M., Yaman S., Can F., et al.

Indian Journal of Hematology and Blood Transfusion , cilt.42, sa.1, ss.110-119, 2026 (SCI-Expanded, Scopus)

5. Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center

Aydin M. S., Korkmaz G., Pamukcuoglu M., Guner H. R., CERAN F., DAĞDAŞ S., et al.

Mediterranean Journal of Hematology and Infectious Diseases , cilt.18, sa.1, 2026 (SCI-Expanded, Scopus)

6. Clinical Associations of Osteoporosis in BCR::ABL1 Negative Myeloproliferative Neoplasms

Aydin M. S., DAĞDAŞ S., Pepeler M. S., Korkmaz G., Alper A., Açıkgöz E., et al.

International Journal of Endocrinology , cilt.2026, sa.1, 2026 (SCI-Expanded, Scopus)

7. Ocular surface and corneal subbasal nerve plexus changes in ocular graft versus host disease patients treated with topical cyclosporine

KARACA E. E., Kemer Ö. E., DAĞDAŞ S., Asfuroğlu Y., CERAN F., Pepeler M. S., et al.

BMC Ophthalmology , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)

8. Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group

Isleyen E., Alhan N., TERZİ DEMİRSOY E., GEDÜK A., Avci D. N., Yeral M., et al.

Journal of Clinical Medicine , cilt.14, sa.19, 2025 (SCI-Expanded, Scopus)

9. Effectiveness and safety of therapeutic plasma exchange in neurological diseases: An 11-year report from a tertiary care center

Korkmaz G., DAĞDAŞ S., Saltoglu T., CERAN F., Aydın M. S., BEKTAŞ H., et al.

Therapeutic Apheresis and Dialysis , cilt.29, sa.2, ss.312-320, 2025 (SCI-Expanded, Scopus)

10. What is the role of alpha-1 antitrypsin in the management of acute graft versus host disease?

YİĞENOĞLU T. N., ERKURT M. A., DAĞDAŞ S., Ulu B. U., KUKU İ., Durdu A., et al.

Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded, Scopus)

11. Different Presentations and Different Treatment Options in Blastic Plasmacytoid Dendritic Cell Neoplasms: A Case Series

Cengiz E., Aydin M. S., GÜNEŞ A. K., CERAN F., DAĞDAŞ S., Ozet G.

International Journal of Hematology-Oncology and Stem Cell Research , cilt.19, sa.1, ss.81-85, 2025 (Scopus)

12. Clinical Manifestations, Treatment Characteristics, and Clinical Outcomes in Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP) in a Real-World Setting: An Interim Analysis of the Turkish iTTP Registry İmmün Trombotik Trombositopenik Purpura (iTTP) Hastalarının Klinik Bulguları, Tedavi Özellikleri ve Klinik Sonuçlarının Gerçek Yaşam Değerlendirmesi: Türk iTTP Kayıt Çalışması Ara Analizi

Karakuş S., BAKANAY ÖZTÜRK Ş. M., BEŞIŞIK S., EŞKAZAN A. E., Ayyıldız O., GÜRKAN E., et al.

Turkish Journal of Hematology , cilt.42, sa.3, ss.203-212, 2025 (SCI-Expanded, Scopus, TRDizin)

13. What Happened Suddenly-Acute Abdomen? A Difficult Case of ATRA-Related Pneumatosis Cystoides Intestinalis Aniden Ne Oldu: Akut Abdomen? ATRA İlişkili Pnömatozis Sistoides İntestinalis Gelişen Zor Olgu

Yön M. E. E., Ceylan A., Kaya E. İ., Ölçücüoğlu E., CERAN F., DAĞDAŞ S., et al.

Turkish Journal of Hematology , cilt.42, sa.2, ss.150-152, 2025 (SCI-Expanded, Scopus, TRDizin)

14. Prognostic Role of Neutrophil to Lymphocyte Ratio at Diagnosis in Patients with Diffuse Large B-Cell Lymphoma

Korkmaz G., CERAN F., DAĞDAŞ S., GÜNEŞ A. K., Sunu C., Pepeler M., et al.

Nigerian Journal of Clinical Practice , cilt.27, sa.8, ss.1012-1019, 2024 (SCI-Expanded, Scopus)

15. Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience

Kilic Gunes E., YİĞİT KAYA S., YAMAN F., Yeniay M. K., Vural K., Comert M., et al.

Leukemia Research , cilt.140, 2024 (SCI-Expanded, Scopus)

16. Prognostic Impact of Bone Marrow Fibrosis and Effects of Tyrosine Kinase Inhibitors on Bone Marrow Fibrosis in Chronic Myeloid Leukemia

Pepeler M. S., Tıglıoglu M., DAĞDAŞ S., Ozhamamcıoglu E., Han U., Albayrak A., et al.

Clinical Lymphoma, Myeloma and Leukemia , cilt.24, sa.4, 2024 (SCI-Expanded, Scopus)

17. Deferoxamine-related bilateral maculopathy with optical coherence tomography findings

Bayraktar Bilen N., Polat Gültekin B., DAĞDAŞ S., KALAYCI D.

Photodiagnosis and Photodynamic Therapy , cilt.45, 2024 (SCI-Expanded, Scopus)

18. Daratumumab and Eltrombopag for Pure Red Cell Aplasia Following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia ABO Kan Grubu Uyumsuz Allojenik Hematopoetik Kök Hücre Nakli Olan Hastada Gelişen Saf Eritroid Hücre Aplazisinde Daratumumab ve Eltrombopag Kullanımı

Pepeler M. S., DAĞDAŞ S., İşleyen E., Katayıfçı G., Kılıçarslan A., Özhamam E., et al.

Turkish Journal of Hematology , cilt.41, sa.4, ss.288-290, 2024 (SCI-Expanded, Scopus, TRDizin)

19. Effect of Mobilization Methods on CD34+ and Total Nucleated Cell Count and Their relation with Engraftment in Autologous Hematopoietic Stem Cell Transplantation

Beyler Ö., Pamukcuoğlu M., GÜNEŞ A. K., Korkmaz G., Ulusoy G., CERAN F., et al.

Eastern Journal of Medicine , cilt.29, sa.3, ss.344-348, 2024 (Scopus, TRDizin)

20. Ibrutinib combined with gemcitabine-vinorelbine for primary refractory non-Hodgkin lymphoma

Aydin M. S., Cengiz E., Can F., DAĞDAŞ S., DİLEK İ., Ozet G.

Blood Research , cilt.58, sa.4, ss.234-237, 2023 (ESCI, Scopus)

21. A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometry

Ozdemir Z. N., Falay M., Parmaksiz A., Genc E., Beyler O., GÜNEŞ A. K., et al.

Hematology, Transfusion and Cell Therapy , cilt.45, sa.2, ss.176-181, 2023 (ESCI, Scopus)

22. Outcomes of COVID-19 Patients Undergoing Therapeutic Plasma Exchange in Intensive Care Units

Aydin M. S., Pepeler M. S., Akdag A. G., GÖKBULUT BEKTAŞ Ş., ERDEM D., GÖKÇINAR D., et al.

Journal of Critical and Intensive Care , cilt.14, sa.2, ss.41-46, 2023 (ESCI, Scopus, TRDizin)

23. The Role of Plasmapheresis in Acute Rejection with Decompensated Heart Failure after Heart Transplantation Kalp Nakli Sonrası Dekompanze Kalp Yetmezliğine Neden Olan Akut Rejeksiyonda Plazmaferezin Rolü

Karahan M., Sert D. E., Yilmaz A., Yamac F., Turgut S., DEMİRKAN B., et al.

Genel Tip Dergisi , cilt.32, sa.6, ss.719-723, 2022 (Scopus, TRDizin)

24. Predictive Factors for Molecular Response in Chronic Myeloid Leukemia: Reduction Ratio and Halving Time of BCR::ABL1 IS Transcript Levels Kronik Myeloid Lösemide Moleküler Yanıtı Öngörücü Faktörler: BCR::ABL1 IS Transkript Seviyelerinin Azalma Oranı ve Yarılanma Zamanı

CERAN F., Akıncı S., Uçar M. A., Korkmaz G., Gündüz M., Çavdarlı B., et al.

Turkish Journal of Hematology , cilt.39, sa.3, ss.196-203, 2022 (SCI-Expanded, Scopus, TRDizin)

25. Real world results of venetoclax combined with hypomethylating agents in relapsed/refractory AML

Ucar M., Ozet G., Koyuncu M., SÖNMEZ M., Akidan O., AYLI M. D., et al.

European Review for Medical and Pharmacological Sciences , cilt.25, sa.21, ss.6557-6565, 2021 (SCI-Expanded, Scopus)

26. Conditioning Regimens for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Stem Cell Transplantation: BEAM Versus High Dose ICE

GÜNEŞ A. K., DAĞDAŞ S., CERAN F., Ucar M. A., Falay M., Sunu C., et al.

Indian Journal of Hematology and Blood Transfusion , cilt.37, sa.1, ss.82-89, 2021 (SCI-Expanded, Scopus)

27. The evaluation of patients with essential thrombocythemia in terms of risk of thrombosis

Sunu C., GÜNEŞ A. K., Akat G. K., Kalpakci Y., CERAN F., DAĞDAŞ S., et al.

Revista da Associacao Medica Brasileira , cilt.67, sa.3, ss.385-389, 2021 (SCI-Expanded, Scopus)

28. Prognostic Value of Baseline Serum Lactate Dehydrogenase Level in Patients With Hairy Cell Leukemia

Maral S., ALBAYRAK M., DAĞDAŞ S., Yıldız A., Yıldırım R., Oz M., et al.

Clinical Lymphoma, Myeloma and Leukemia , cilt.20, sa.9, 2020 (SCI-Expanded, Scopus)

29. Comparison of allogenic stem cell transplantations performed with frozen or fresh stem cell products with regard to GVHD and mortality

DAĞDAŞ S., Ucar M. A., CERAN F., GÜNEŞ A. K., Falay M., Ozet G.

Transfusion and Apheresis Science , cilt.59, sa.4, 2020 (SCI-Expanded, Scopus)

30. IS DYNAMIC THIOL/DISULFIDE HOMEOSTASIS ASSOCIATED WITH THE PROGNOSIS OF MYELODYSPLASTIC SYNDROME? POVEZANOST DINAMICNE TIOL/DISULFIDNE HOMEOSTAZE SA PROGNOZOM MIJELODISPLAZNOG SINDROMA

Ucar M. A., Tombak A., DAĞDAŞ S., Akdeniz A., CERAN F., NEŞELİOĞLU S., et al.

Journal of Medical Biochemistry , cilt.39, sa.3, ss.336-345, 2020 (SCI-Expanded, Scopus)

31. Aspergillus and nocardia coinfection in a patient with allogeneic stem cell transplantation Alojenik kök hücre nakli yapılan bir hastada aspergillus ve nocardia koinfeksiyonu

Araz H., Kocagül-çelikbaş A., HAZIROLAN G., DAĞDAŞ S., CERAN F., Taşpınar E., et al.

Klimik Dergisi , cilt.32, sa.2, ss.195-199, 2019 (Scopus)

32. The Turkish experience with therapeutic plasma exchange: A national survey

KORKMAZ S., Solmaz Medeni S., Demirkan F., BEŞIŞIK S., Altay Dadin S., Akgun Cagliyan G., et al.

Transfusion and Apheresis Science , cilt.58, sa.3, ss.287-292, 2019 (SCI-Expanded, Scopus)

33. The importance of RET-He in the diagnosis of iron deficiency and iron deficiency anemia and the evaluation of response to oral iron therapy

Uçar M. A., Falay M., DAĞDAŞ S., CERAN F., Urlu S. M., Özet G.

Journal of Medical Biochemistry , cilt.38, sa.4, ss.496-502, 2019 (Scopus)

34. Which Markers Should the used for Diagnostic Chronic Lymphocytic Leukemia Immunophenotyping Scoring System by Flow Cytometry?

Falay M., SERDAR M. A., Dalgali H., Uçar M. A., DAĞDAŞ S., Özet G.

Clinical Laboratory , cilt.65, sa.11, ss.2049-2055, 2019 (SCI-Expanded, Scopus)

35. Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome–positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up

Saydam G., HAZNEDAROĞLU İ. C., KAYNAR L., Yavuz A. S., Ali R., GÜVENÇ B., et al.

Hematology , cilt.23, sa.10, ss.771-777, 2018 (SCI-Expanded, Scopus)

36. What should be the laboratory approach against isolated prolongation of a activated partial thromboplastin time?

Falay M., ŞENEŞ M., YÜCEL D., TURHAN T., DAĞDAŞ S., Pekin M., et al.

Journal of Clinical Laboratory Analysis , cilt.32, sa.6, 2018 (SCI-Expanded, Scopus)

37. The role of CD200 and CD43 expression in differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma Kronik lenfositik lösemi ve mantle hücreli lenfoma ayırıcı tanısında cd200 ve cd43 ekspresyonunun rolü

Falay M., Öztürk B. A., Güneş K., Kalpakçı Y., DAĞDAŞ S., CERAN F., et al.

Turkish Journal of Hematology , cilt.35, sa.2, ss.94-98, 2018 (SCI-Expanded, Scopus, TRDizin)

38. Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG)

Tekgündüz E., Demirkan F., Vural F., GÖKER H., Özdoğu H., KİKİ İ., et al.

Transfusion and Apheresis Science , cilt.56, sa.6, ss.804-808, 2017 (SCI-Expanded, Scopus)

39. Evaluation of Lymphoma Patients Receiving High-Dose Therapy and Autologous Stem Cell Transplantation: Experience of a Single Center

Bozkaya Y., Uncu D., DAĞDAŞ S., ERDEM G. U., DOĞAN M., Özet G., et al.

Indian Journal of Hematology and Blood Transfusion , cilt.33, sa.3, ss.361-369, 2017 (SCI-Expanded, Scopus)

40. The assessment of CD56 and CD117 expressions at the time of the diagnosis in multiple myeloma patients Multipl Miyeloma Hastalarında Tanı Sırasında CD56 ve CD117 Ekspresyonlarının Değerlendirilmesi

CERAN F., Falay M., DAĞDAŞ S., Özet G.

Turkish Journal of Hematology , cilt.34, sa.3, ss.226-232, 2017 (SCI-Expanded, Scopus, TRDizin)

41. Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase

Saydam G., HAZNEDAROĞLU İ. C., KAYNAR L., Yavuz A. S., Ali R., GÜVENÇ B., et al.

Expert Opinion on Pharmacotherapy , cilt.17, sa.14, ss.1851-1858, 2016 (SCI-Expanded, Scopus)

42. Determination of HLA-G Expression and Evaluation of Its Role as a Prognostic Factor in Chronic Lymphocytic Leukemia

Ozet G., Falay M., DAĞDAŞ S., CERAN F.

Journal of Clinical Laboratory Analysis , cilt.30, sa.5, ss.399-403, 2016 (SCI-Expanded, Scopus)

43. CD38 expression and variation as a prognostic factor chronic lymphocytic leukemia

Falay M., CERAN F., GÜNEŞ A. K., DAĞDAŞ S., AYLI M., Ozet G.

Clinical Laboratory , cilt.62, sa.7, ss.1287-1293, 2016 (SCI-Expanded, Scopus)

44. Clinical significance of CD87 expression in acute myeloblastic leukemia Akut miyeloblastik lösemide CD87 ekspresyonunun klinik önemi

CERAN F., Ozet G., DAĞDAŞ S., Falay M., ALBAYRAK M., Yokus O., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.26, sa.1, ss.47-53, 2016 (SCI-Expanded, Scopus, TRDizin)

45. Conventional cytogenetics and fish [del13q, del17p, t(11;14), t(4;14)] findings and their relationship with other risk factors in multiple myeloma Multipl myelomda konvansiyonel sitogenetik ve fish [del13q, del17p, t(11;14), t(4;14)] bulgulari ve diǧer risk faktörleri ile Iliflkisi

Balcik O. S., ALBAYRAK M., DAĞDAŞ S., Helvaci N., Yokus O., CERAN F., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.21, sa.4, ss.203-209, 2011 (SCI-Expanded, Scopus, TRDizin)

46. Serum thrombin activatable fibrinolysis inhibitor levels in patients with newly diagnosed multiple myeloma

Balcik O. S., ALBAYRAK M., Uyar M. E., DAĞDAŞ S., Yokus O., CERAN F., et al.

Blood Coagulation and Fibrinolysis , cilt.22, sa.4, ss.260-263, 2011 (SCI-Expanded, Scopus)

47. Assessment of plasma endostatin levels in patients with acute myeloblastic and lymphoblastic leukemia Akut myeloblastik ve lenfoblastik lösemili hastalarda plazma endostatin düzeylerinin deǧerlendirilmesi

DAĞDAŞ S., Ozet G., Yilmaz M., ALBAYRAK M., CERAN F.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.21, sa.4, ss.210-216, 2011 (SCI-Expanded, Scopus, TRDizin)

48. A rare extramedullar involvement in myeloma: Lung parenchyma and association with unfavorable chromosomal abnormalities Miyelom'da nadir bir ekstramedüller tutulum: Akciǧer parankimi ve olumsuz kromozomal anormalliklerle ilişkisi

Balçik Ö. Ş., ALBAYRAK M., DAĞDAŞ S., CERAN F., Özet G., DEMİRAĞ F., et al.

Turkish Journal of Hematology , cilt.27, sa.2, ss.109-112, 2010 (Scopus, TRDizin)

49. Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality

ÖNGÜRÜ P., DAĞDAŞ S., BODUR H., Yilmaz M., AKINCI E., Eren S., et al.

Journal of Clinical Laboratory Analysis , cilt.24, sa.3, ss.163-166, 2010 (SCI-Expanded, Scopus)

50. Evaluation of risk factors for thrombophilia in patients with cerebral venous thrombosis Serebral venöz tromboz geçiren hastaların trombofilik risk faktörleri açisından deǧerlendirilmesi

Yokşu O., Balçik Ö. Ş., ALBAYRAK M., CERAN F., DAĞDAŞ S., Yilmaz M., et al.

Turkish Journal of Hematology , cilt.27, sa.3, ss.162-167, 2010 (Scopus, TRDizin)

51. A case of multicentric HHV-8 positive Castleman's disease presenting with marked lymphocytosis

DAĞDAŞ S., ALBAYRAK M., Balçik Ö. Ş., Özet G., CERAN F., Erekul S.

Turkish Journal of Cancer , cilt.39, sa.3, ss.110-114, 2009 (Scopus)

52. Risk factors for thrombophilia in young adults presenting with thrombosis

Yokus O., ALBAYRAK M., Balcik O. S., CERAN F., DAĞDAŞ S., Yilmaz M., et al.

International Journal of Hematology , cilt.90, sa.5, ss.583-590, 2009 (SCI-Expanded, Scopus)

53. Effects of imatinib mesylate on Renin-Angiotensin System (RAS) activity during the clinical course of chronic myeloid leukaemia

SAYİTOĞLU M., HAZNEDAROĞLU İ. C., Hatirnaz O., ERBİLGİN Y., AKSU S., Koca E., et al.

Journal of International Medical Research , cilt.37, sa.4, ss.1018-1028, 2009 (SCI-Expanded, Scopus)

54. Development of multiple myeloma in the course of chronic lymphocytic leukemia: Case report Kronik lenfositik lösemi seyrinde multipl miyelom gelişimi: Olgu sunumu

Balçik Ö. Ş., DAĞDAŞ S., ALBAYRAK M., Efe C., Yokuş O., CERAN F., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.18, sa.4, ss.238-241, 2008 (Scopus, TRDizin)

55. The effect of regimes of harvesting autologous peripheric stem cell on the number of CD34(+) cell: Experience at a single center Otolog periferik kök hücre toplama rejimlerinin CD34(+) hücre sayisi üzerine etkisi: Tek merkez deneyimi

Şahin Balçik Ö., DAĞDAŞ S., Keser Güler S., Özet G., Oymak A., Çelik Z., et al.

Turkiye Klinikleri Journal of Medical Sciences , cilt.28, sa.5, ss.640-647, 2008 (Scopus)

56. An unusual case of spontaneous acute tumor lysis syndrome associated with acute lymphoblastic leukemia: A case report and review of the literature [3]

Akoz A. G., Yildirim N., Engin H., DAĞDAŞ S., Ozet G., Tekin I. O., et al.

Acta Oncologica , cilt.46, sa.8, ss.1190-1192, 2007 (SCI-Expanded, Scopus)

57. Isolated central nervous system relapse during cytologic and molecular hematologic remission in two patients with acute promyelocytic leukemia

Akoz A. G., DAĞDAŞ S., Ozet G., CERAN F., Yilmaz M.

Hematology , cilt.12, sa.5, ss.419-422, 2007 (SCI-Expanded, Scopus)

58. Bilateral proptosis as the initial presentation of systemic nodular lymphocyte predominant Hodgkin lymphoma [8]

Akoz A. G., DAĞDAŞ S., Soysal H., Ozet G., Ustun H.

Leukemia and Lymphoma , cilt.48, sa.7, ss.1434-1436, 2007 (SCI-Expanded, Scopus)

59. The relation between plasminogen activator inhibitor activity and disease activation in acute myeloblastic leukaemia patients

Yilmaz M., DAĞDAŞ S., Aki S., Guler N., Akoz A., Erdin Z., et al.

Clinical and Laboratory Haematology , cilt.28, sa.5, ss.313-316, 2006 (SCI-Expanded, Scopus)

60. Unusual extramedullar hematopoiesis in a patient receiving granulocyte colony-stimulating factor

DAĞDAŞ S., Ozet G., Alanoglu G., AYLI M., Akoz A. G., Erekul S.

Acta Haematologica , cilt.116, sa.3, ss.198-202, 2006 (SCI-Expanded, Scopus)

61. Plasma levels of thrombin-activatable fibrinolysis inhibitor in primary and secondary thrombocytosis

Kaftan O., Balcik O., Cipil H., Ozet G., Bavbek N., Koşar A., et al.

Clinical and Applied Thrombosis/Hemostasis , cilt.11, sa.4, ss.449-454, 2005 (SCI-Expanded, Scopus)

62. The plateled-derived growth factor level (PDGF) in Hodgkin's disease and non-Hodgkin's lymphoma and its relationship disease activation

Güler N., Yilmaz S., Ayaz S., Yilmaz M., Aki Z., DAĞDAŞ S., et al.

Hematology , cilt.10, sa.1, ss.53-57, 2005 (Scopus)

63. Bacterial pyomyositis in a patient with adult acute lymphoblastic leukaemia

Aki Z., DAĞDAŞ S., Akoz A. G., Erdem Z. E., Yilmaz M., Guler N., et al.

HAEMA , cilt.7, sa.3, ss.374-377, 2004 (Scopus)

64. Hypercalcemia and multiple pathological fractures in chronic lymphocytic leukaemia: A case report

Alanoǧlu G., DAĞDAŞ S., Aki Z., Yaǧmurlu F., Özet G.

Turkish Journal of Haematology , cilt.20, sa.3, ss.167-170, 2003 (Scopus)

65. Lamivudine therapy in acute leukemia patients who are hepatitis B surface antigen carriers

Yilmaz M., DAĞDAŞ S., Güler N., Aki S. Z., Aköz A. G., Özet G., et al.

Hematology , cilt.8, sa.6, ss.393-396, 2003 (Scopus)

66. Isolated acquired FX deficiency: A case report

AYLI M., DAĞDAŞ S., Yilmaz S.

Turkish Journal of Haematology , cilt.17, sa.1, ss.29-32, 2000 (Scopus, TRDizin)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Açık Erişim